 Camptothecins are among the most effective anticancer agents recently introduced into clinical practice.In this regard, the camptothecin derivative topotecan (Hycamtin) is approved by the U.S. FDA for the treatment of ovarian and lung cancer.Another camptothecin derivative irinotecan (CPT11) is approved for the treatment of colon cancer.